1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,000 | 8,000 | 11:42 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.03. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 287 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 19.02. | ABL Diagnostics S.A.: ABL Diagnostics Update Regarding Non-Binding Letter of Intent | 300 | Business Wire | Regulatory News:
ABL Diagnostics S.A. (Euronext: ABLD ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into between ProPhase Labs, Inc. and Advanced Biological... ► Artikel lesen | |
| 13.02. | ABL Diagnostics SA: ABL SA Executes the First Purchase Notice of ABL Diagnostics Shares With Alumni Capital | 502 | Business Wire | Regulatory News:
ISIN: FR001400AHX6 Euronext Paris
ABL Diagnostics SA ("the Company") (Paris:ABLD) informs the public that its principal shareholder, Advanced Biological Laboratories SA (ABL... ► Artikel lesen | |
| 03.02. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 357 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 19.12.25 | ABL Diagnostics Informs the Market of a Non-Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger | 427 | Business Wire | The contemplated transaction remains subject to due diligence, definitive agreements, regulatory approvals and Nasdaq listing requirements; no change to ABL S.A.'s control over ABL Diagnostics at... ► Artikel lesen | |
| 05.12.25 | ABL Diagnostics S.A.: Information on a Temporary Transfer of ABL Diagnostics Shares | 394 | Business Wire | Regulatory News:
ABL Diagnostics S.A. (ISIN: FR001400AHX6, ticker: ABLD, listed on Euronext Paris) informs its shareholders and the market that a temporary transfer of 128,026 shares of the company... ► Artikel lesen | |
| ABL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 14.11.25 | ABL Diagnostics Appoints Eurobio Scientific as Exclusive Distributor for Its VELA Product Line in a Targeted Segment of the French Market | 358 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distribution agreement with Eurobio... ► Artikel lesen | |
| 22.10.25 | ABL Diagnostics SA: ABL Diagnostics - Announcement of a Second Agreement Between ABL SA and Alumni Capital | 308 | Business Wire | Regulatory News:
ISIN: FR001400AHX6 Euronext Paris
ABL Diagnostics SA (the "Company") (Paris:ABLD) informs the public that Advanced Biological Laboratories SA (ABL SA), its parent company, announced... ► Artikel lesen | |
| 16.10.25 | ABL Diagnostics SA: ABL Diagnostics: Switch to Continuous Trading on Euronext Paris as From November 3rd, 2025 | 381 | Business Wire | Regulatory News:
ABL Diagnostics (Euronext Paris: ABLD ISIN: FR001400AHX6) announces the switch from a fixing-based trading mode to continuous trading as from November 3rd, 2025, in accordance... ► Artikel lesen |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 38,640 | +0,91 % | Multinational Execs in China Must Act as Entrepreneurs, Siemens Healthineers Country President Says | ||
| THERMO FISHER | 446,70 | -0,13 % | Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities | ||
| STRATEC | 18,660 | -1,27 % | STRATEC SE bestätigt ihre fundamentale Stärke | ||
| UNIDOC HEALTH | 0,055 | -1,78 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| DIASORIN | 63,48 | +0,63 % | DiaSorin FY Net Result Down | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI, DSRLF, DIAS.MI) reported that its net result for fiscal year 2025 declined to 150 million euros from 187 million euros last year.But net revenues for... ► Artikel lesen | |
| BIOCARTIS | 0,259 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.01.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 21.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.01.2026ISIN NameBE0974281132 BIOCARTIS... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,280 | 0,00 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| PROGYNY | 17,170 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ADAPTHEALTH | 12,770 | +3,65 % | AdaptHealth refinances $1.1B senior secured credit facility | ||
| FRESENIUS MEDICAL CARE | 39,150 | -1,26 % | Shortseller-Positionen aktuell: u.a. Carl Zeiss Meditec, Evonik, FMC, Gerresheimer, GFT, MTU, Nordex, Ströer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| FRESENIUS | 44,840 | -0,02 % | Fresenius: S&P Global erhöht Ausblick - jetzt zugreifen? | Unter der Leitung von Konzernchef Michael Sen hat sich Fresenius einem Umbau unterzogen. Randbereiche wurden verkauft, die Effizienz gesteigert und schlussendlich auch der Schuldenabbau forciert. Das... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 46,040 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,780 | +0,51 % | Eckert & Ziegler erhält MDR-Zertifizierung für Augentumorbehandlung | Die Eckert & Ziegler BEBIG GmbH, eine auf Brachytherapie spezialisierte Tochtergesellschaft der Eckert & Ziegler SE, hat die MDR-Zertifizierung der EU für ihre Ruthenium-106-Augenapplikatoren erhalten.... ► Artikel lesen | |
| HEARTFLOW | 29,020 | 0,00 % | Heartflow, Inc.: Heartflow Files Patent Infringement Lawsuit Against Cleerly | MOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,420 | +1,18 % | EILMELDUNG bei Carl Zeiss Meditec: Das Signal das die meisten Anleger noch nicht kennen - Was ich konkret unternommen habe |
Das Unternehmen ABL DIAGNOSTICS SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,500 Euro und damit -3,10 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ABL DIAGNOSTICS SA finden Sie auf Wallstreet Online.